PubMed:19219548
Annnotations
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 14-30 | Glycan_Motif | denotes | lactosylceramide | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G74621DY|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G20420WT |
T4 | 256-272 | Glycan_Motif | denotes | lactosylceramide | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G74621DY|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G20420WT |
T7 | 274-280 | Glycan_Motif | denotes | LacCer | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW |
T8 | 286-292 | Glycan_Motif | denotes | LacCer | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW |
T9 | 389-395 | Glycan_Motif | denotes | LacCer | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW |
T10 | 548-554 | Glycan_Motif | denotes | LacCer | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW |
T11 | 1034-1040 | Glycan_Motif | denotes | LacCer | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW |
T12 | 1157-1173 | Glycan_Motif | denotes | glucosylceramide | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G71142DF |
T13 | 1187-1193 | Glycan_Motif | denotes | LacCer | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW |
T14 | 1520-1526 | Glycan_Motif | denotes | LacCer | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW |
T15 | 1868-1874 | Glycan_Motif | denotes | LacCer | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-30 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | lactosylceramide |
T2 | 256-272 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | lactosylceramide |
T3 | 274-280 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | LacCer |
T4 | 286-292 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | LacCer |
T5 | 389-395 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | LacCer |
T6 | 548-554 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | LacCer |
T7 | 1034-1040 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | LacCer |
T8 | 1187-1193 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | LacCer |
T9 | 1520-1526 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | LacCer |
T10 | 1868-1874 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | LacCer |
Glycosmos6-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 498-503 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colon |
T2 | 613-618 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colon |
T3 | 1222-1226 | http://purl.obolibrary.org/obo/MAT_0000037 | denotes | vein |
T4 | 2034-2039 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colon |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-125 | Sentence | denotes | VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. |
TextSentencer_T2 | 126-202 | Sentence | denotes | Angiogenesis is largely driven by vascular endothelial growth factor (VEGF). |
TextSentencer_T3 | 203-341 | Sentence | denotes | However, the role of lipid second messengers such as lactosylceramide (LacCer) and LacCer synthase in angiogenesis is not well understood. |
TextSentencer_T4 | 342-474 | Sentence | denotes | We have determined the distribution of various LacCer synthase mRNA transcripts using sequential analysis of gene expression (SAGE). |
TextSentencer_T5 | 475-644 | Sentence | denotes | Endothelial cells from colon cancer tissues had a 4.5-fold increase in a LacCer synthase transcript (beta1,4GalT-V) as compared to normal colon tissue endothelial cells. |
TextSentencer_T6 | 645-778 | Sentence | denotes | Consequently, our focus turned to understanding the role of this enzyme in regulating VEGF-induced angiogenesis in vitro and in vivo. |
TextSentencer_T7 | 779-1056 | Sentence | denotes | Herein, we show that in human endothelial cells, VEGF-induced angiogenesis is mitigated by dimethylsphingosine and suramin; inhibitors of sphingosine kinase 1(SphK-1) and sphingosine1-phosphate receptor 1(S1P (1)), respectively, and this were bypassed by LacCer but not by S1P. |
TextSentencer_T8 | 1057-1295 | Sentence | denotes | VEGF and basic fibroblast growth factor-induced angiogenesis was mitigated by PDMP; an inhibitor of glucosylceramide synthase and LacCer synthase in human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC). |
TextSentencer_T9 | 1296-1394 | Sentence | denotes | Likewise, GalT-V gene ablation using corresponding siRNA also mitigated VEGF-induced angiogenesis. |
TextSentencer_T10 | 1395-1545 | Sentence | denotes | In Matrigel plug angiogenesis assay in nude mice, angiogenesis was markedly inhibited by D-PDMP with concordantly diminished LacCer synthase activity. |
TextSentencer_T11 | 1546-1817 | Sentence | denotes | Mechanistic studies revealed that the use of LY294002, a PI3 kinase inhibitor, mitigated VEGF-induced expression of platelet-endothelial cell adhesion molecule (PECAM-1/CD31); the trans-endothelial migration of a monocyte cell line (U-937) and angiogenesis in HAEC cells. |
TextSentencer_T12 | 1818-2047 | Sentence | denotes | Since this enzyme is a target for VEGF action and LacCer serves as a lipid second messenger in inducing angiogenesis in vitro and in vivo, novel therapeutic approaches may be developed using our findings to mitigate colon cancer. |
T1 | 0-125 | Sentence | denotes | VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. |
T2 | 126-202 | Sentence | denotes | Angiogenesis is largely driven by vascular endothelial growth factor (VEGF). |
T3 | 203-341 | Sentence | denotes | However, the role of lipid second messengers such as lactosylceramide (LacCer) and LacCer synthase in angiogenesis is not well understood. |
T4 | 342-474 | Sentence | denotes | We have determined the distribution of various LacCer synthase mRNA transcripts using sequential analysis of gene expression (SAGE). |
T5 | 475-644 | Sentence | denotes | Endothelial cells from colon cancer tissues had a 4.5-fold increase in a LacCer synthase transcript (beta1,4GalT-V) as compared to normal colon tissue endothelial cells. |
T6 | 645-778 | Sentence | denotes | Consequently, our focus turned to understanding the role of this enzyme in regulating VEGF-induced angiogenesis in vitro and in vivo. |
T7 | 779-1056 | Sentence | denotes | Herein, we show that in human endothelial cells, VEGF-induced angiogenesis is mitigated by dimethylsphingosine and suramin; inhibitors of sphingosine kinase 1(SphK-1) and sphingosine1-phosphate receptor 1(S1P (1)), respectively, and this were bypassed by LacCer but not by S1P. |
T8 | 1057-1295 | Sentence | denotes | VEGF and basic fibroblast growth factor-induced angiogenesis was mitigated by PDMP; an inhibitor of glucosylceramide synthase and LacCer synthase in human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC). |
T9 | 1296-1394 | Sentence | denotes | Likewise, GalT-V gene ablation using corresponding siRNA also mitigated VEGF-induced angiogenesis. |
T10 | 1395-1545 | Sentence | denotes | In Matrigel plug angiogenesis assay in nude mice, angiogenesis was markedly inhibited by D-PDMP with concordantly diminished LacCer synthase activity. |
T11 | 1546-1817 | Sentence | denotes | Mechanistic studies revealed that the use of LY294002, a PI3 kinase inhibitor, mitigated VEGF-induced expression of platelet-endothelial cell adhesion molecule (PECAM-1/CD31); the trans-endothelial migration of a monocyte cell line (U-937) and angiogenesis in HAEC cells. |
T12 | 1818-2047 | Sentence | denotes | Since this enzyme is a target for VEGF action and LacCer serves as a lipid second messenger in inducing angiogenesis in vitro and in vivo, novel therapeutic approaches may be developed using our findings to mitigate colon cancer. |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-30 | https://glytoucan.org/Structures/Glycans/G20420WT | denotes | lactosylceramide |
T2 | 14-30 | https://glytoucan.org/Structures/Glycans/G74621DY | denotes | lactosylceramide |
T3 | 14-30 | https://glytoucan.org/Structures/Glycans/G84224TW | denotes | lactosylceramide |
T4 | 256-272 | https://glytoucan.org/Structures/Glycans/G20420WT | denotes | lactosylceramide |
T5 | 256-272 | https://glytoucan.org/Structures/Glycans/G74621DY | denotes | lactosylceramide |
T6 | 256-272 | https://glytoucan.org/Structures/Glycans/G84224TW | denotes | lactosylceramide |
T7 | 1157-1173 | https://glytoucan.org/Structures/Glycans/G71142DF | denotes | glucosylceramide |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 498-510 | Disease | denotes | colon cancer | http://purl.obolibrary.org/obo/MONDO_0021063 |
T2 | 2034-2046 | Disease | denotes | colon cancer | http://purl.obolibrary.org/obo/MONDO_0021063 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 498-510 | Phenotype | denotes | colon cancer | HP:0003003 |
T2 | 2034-2046 | Phenotype | denotes | colon cancer | HP:0003003 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 14-30 | Glycan | denotes | lactosylceramide | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T2 | 256-272 | Glycan | denotes | lactosylceramide | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T3 | 274-280 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T4 | 286-292 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T5 | 389-395 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T6 | 548-554 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T7 | 1034-1040 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T8 | 1187-1193 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T9 | 1520-1526 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T10 | 1868-1874 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 14-30 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | lactosylceramide | http://www.glycoepitope.jp/epitopes/EP0078 |
T2 | 256-272 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | lactosylceramide | http://www.glycoepitope.jp/epitopes/EP0078 |
T3 | 274-280 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T4 | 286-292 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T5 | 389-395 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T6 | 548-554 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T7 | 1034-1040 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T8 | 1187-1193 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T9 | 1520-1526 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T10 | 1868-1874 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 498-510 | Phenotype | denotes | colon cancer | HP:0003003 |
T2 | 2034-2046 | Phenotype | denotes | colon cancer | HP:0003003 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 498-510 | Disease | denotes | colon cancer | http://purl.obolibrary.org/obo/MONDO_0021063 |
T2 | 2034-2046 | Disease | denotes | colon cancer | http://purl.obolibrary.org/obo/MONDO_0021063 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 803-808 | OrganismTaxon | denotes | human | 9606 |
T2 | 1206-1211 | OrganismTaxon | denotes | human | 9606 |
T3 | 1257-1262 | OrganismTaxon | denotes | human | 9606 |
T4 | 1439-1443 | OrganismTaxon | denotes | mice | 10088 |
GlyCosmos15-CL
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 41-57 | Cell | denotes | endothelial cell | http://purl.obolibrary.org/obo/CL:0000115 |
T2 | 475-492 | Cell | denotes | Endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |
T3 | 626-643 | Cell | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |
T4 | 809-826 | Cell | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |
T5 | 1072-1082 | Cell | denotes | fibroblast | http://purl.obolibrary.org/obo/CL:0000057 |
T6 | 1222-1244 | Cell | denotes | vein endothelial cells | http://purl.obolibrary.org/obo/CL:0002543 |
T7 | 1263-1287 | Cell | denotes | aortic endothelial cells | http://purl.obolibrary.org/obo/CL:0002544 |
T8 | 1662-1670 | Cell | denotes | platelet | http://purl.obolibrary.org/obo/CL:0000233 |
T9 | 1671-1687 | Cell | denotes | endothelial cell | http://purl.obolibrary.org/obo/CL:0000115 |
T10 | 1759-1767 | Cell | denotes | monocyte | http://purl.obolibrary.org/obo/CL:0000576|http://purl.obolibrary.org/obo/CL:0001054 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 41-57 | Body_part | denotes | endothelial cell | http://purl.obolibrary.org/obo/CL_0000115 |
T2 | 475-492 | Body_part | denotes | Endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T3 | 498-503 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
T4 | 613-618 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
T5 | 619-625 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
T6 | 626-643 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T7 | 809-826 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T8 | 1072-1082 | Body_part | denotes | fibroblast | http://purl.obolibrary.org/obo/CL_0000057 |
T9 | 1212-1226 | Body_part | denotes | umbilical vein | http://purl.obolibrary.org/obo/UBERON_0002066 |
T10 | 1227-1244 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T11 | 1270-1287 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T12 | 1662-1670 | Body_part | denotes | platelet | http://purl.obolibrary.org/obo/CL_0000233 |
T13 | 1671-1687 | Body_part | denotes | endothelial cell | http://purl.obolibrary.org/obo/CL_0000115 |
T14 | 1759-1767 | Body_part | denotes | monocyte | http://purl.obolibrary.org/obo/CL_0000576|http://purl.obolibrary.org/obo/CL_0001054 |
T16 | 2034-2039 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
GlyCosmos15-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 498-503 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/MAT_0000526 |
T2 | 613-618 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/MAT_0000526 |
T3 | 1222-1226 | Body_part | denotes | vein | http://purl.obolibrary.org/obo/MAT_0000037 |
T4 | 2034-2039 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/MAT_0000526 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-125 | Sentence | denotes | VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. |
TextSentencer_T2 | 126-202 | Sentence | denotes | Angiogenesis is largely driven by vascular endothelial growth factor (VEGF). |
TextSentencer_T3 | 203-341 | Sentence | denotes | However, the role of lipid second messengers such as lactosylceramide (LacCer) and LacCer synthase in angiogenesis is not well understood. |
TextSentencer_T4 | 342-474 | Sentence | denotes | We have determined the distribution of various LacCer synthase mRNA transcripts using sequential analysis of gene expression (SAGE). |
TextSentencer_T5 | 475-644 | Sentence | denotes | Endothelial cells from colon cancer tissues had a 4.5-fold increase in a LacCer synthase transcript (beta1,4GalT-V) as compared to normal colon tissue endothelial cells. |
TextSentencer_T6 | 645-778 | Sentence | denotes | Consequently, our focus turned to understanding the role of this enzyme in regulating VEGF-induced angiogenesis in vitro and in vivo. |
TextSentencer_T7 | 779-1056 | Sentence | denotes | Herein, we show that in human endothelial cells, VEGF-induced angiogenesis is mitigated by dimethylsphingosine and suramin; inhibitors of sphingosine kinase 1(SphK-1) and sphingosine1-phosphate receptor 1(S1P (1)), respectively, and this were bypassed by LacCer but not by S1P. |
TextSentencer_T8 | 1057-1295 | Sentence | denotes | VEGF and basic fibroblast growth factor-induced angiogenesis was mitigated by PDMP; an inhibitor of glucosylceramide synthase and LacCer synthase in human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC). |
TextSentencer_T9 | 1296-1394 | Sentence | denotes | Likewise, GalT-V gene ablation using corresponding siRNA also mitigated VEGF-induced angiogenesis. |
TextSentencer_T10 | 1395-1545 | Sentence | denotes | In Matrigel plug angiogenesis assay in nude mice, angiogenesis was markedly inhibited by D-PDMP with concordantly diminished LacCer synthase activity. |
TextSentencer_T11 | 1546-1817 | Sentence | denotes | Mechanistic studies revealed that the use of LY294002, a PI3 kinase inhibitor, mitigated VEGF-induced expression of platelet-endothelial cell adhesion molecule (PECAM-1/CD31); the trans-endothelial migration of a monocyte cell line (U-937) and angiogenesis in HAEC cells. |
TextSentencer_T12 | 1818-2047 | Sentence | denotes | Since this enzyme is a target for VEGF action and LacCer serves as a lipid second messenger in inducing angiogenesis in vitro and in vivo, novel therapeutic approaches may be developed using our findings to mitigate colon cancer. |
T1 | 0-125 | Sentence | denotes | VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. |
T2 | 126-202 | Sentence | denotes | Angiogenesis is largely driven by vascular endothelial growth factor (VEGF). |
T3 | 203-341 | Sentence | denotes | However, the role of lipid second messengers such as lactosylceramide (LacCer) and LacCer synthase in angiogenesis is not well understood. |
T4 | 342-474 | Sentence | denotes | We have determined the distribution of various LacCer synthase mRNA transcripts using sequential analysis of gene expression (SAGE). |
T5 | 475-644 | Sentence | denotes | Endothelial cells from colon cancer tissues had a 4.5-fold increase in a LacCer synthase transcript (beta1,4GalT-V) as compared to normal colon tissue endothelial cells. |
T6 | 645-778 | Sentence | denotes | Consequently, our focus turned to understanding the role of this enzyme in regulating VEGF-induced angiogenesis in vitro and in vivo. |
T7 | 779-1056 | Sentence | denotes | Herein, we show that in human endothelial cells, VEGF-induced angiogenesis is mitigated by dimethylsphingosine and suramin; inhibitors of sphingosine kinase 1(SphK-1) and sphingosine1-phosphate receptor 1(S1P (1)), respectively, and this were bypassed by LacCer but not by S1P. |
T8 | 1057-1295 | Sentence | denotes | VEGF and basic fibroblast growth factor-induced angiogenesis was mitigated by PDMP; an inhibitor of glucosylceramide synthase and LacCer synthase in human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC). |
T9 | 1296-1394 | Sentence | denotes | Likewise, GalT-V gene ablation using corresponding siRNA also mitigated VEGF-induced angiogenesis. |
T10 | 1395-1545 | Sentence | denotes | In Matrigel plug angiogenesis assay in nude mice, angiogenesis was markedly inhibited by D-PDMP with concordantly diminished LacCer synthase activity. |
T11 | 1546-1817 | Sentence | denotes | Mechanistic studies revealed that the use of LY294002, a PI3 kinase inhibitor, mitigated VEGF-induced expression of platelet-endothelial cell adhesion molecule (PECAM-1/CD31); the trans-endothelial migration of a monocyte cell line (U-937) and angiogenesis in HAEC cells. |
T12 | 1818-2047 | Sentence | denotes | Since this enzyme is a target for VEGF action and LacCer serves as a lipid second messenger in inducing angiogenesis in vitro and in vivo, novel therapeutic approaches may be developed using our findings to mitigate colon cancer. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-125 | Sentence | denotes | VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. |
T2 | 126-202 | Sentence | denotes | Angiogenesis is largely driven by vascular endothelial growth factor (VEGF). |
T3 | 203-341 | Sentence | denotes | However, the role of lipid second messengers such as lactosylceramide (LacCer) and LacCer synthase in angiogenesis is not well understood. |
T4 | 342-474 | Sentence | denotes | We have determined the distribution of various LacCer synthase mRNA transcripts using sequential analysis of gene expression (SAGE). |
T5 | 475-644 | Sentence | denotes | Endothelial cells from colon cancer tissues had a 4.5-fold increase in a LacCer synthase transcript (beta1,4GalT-V) as compared to normal colon tissue endothelial cells. |
T6 | 645-778 | Sentence | denotes | Consequently, our focus turned to understanding the role of this enzyme in regulating VEGF-induced angiogenesis in vitro and in vivo. |
T7 | 779-1056 | Sentence | denotes | Herein, we show that in human endothelial cells, VEGF-induced angiogenesis is mitigated by dimethylsphingosine and suramin; inhibitors of sphingosine kinase 1(SphK-1) and sphingosine1-phosphate receptor 1(S1P (1)), respectively, and this were bypassed by LacCer but not by S1P. |
T8 | 1057-1295 | Sentence | denotes | VEGF and basic fibroblast growth factor-induced angiogenesis was mitigated by PDMP; an inhibitor of glucosylceramide synthase and LacCer synthase in human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC). |
T9 | 1296-1394 | Sentence | denotes | Likewise, GalT-V gene ablation using corresponding siRNA also mitigated VEGF-induced angiogenesis. |
T10 | 1395-1545 | Sentence | denotes | In Matrigel plug angiogenesis assay in nude mice, angiogenesis was markedly inhibited by D-PDMP with concordantly diminished LacCer synthase activity. |
T11 | 1546-1817 | Sentence | denotes | Mechanistic studies revealed that the use of LY294002, a PI3 kinase inhibitor, mitigated VEGF-induced expression of platelet-endothelial cell adhesion molecule (PECAM-1/CD31); the trans-endothelial migration of a monocyte cell line (U-937) and angiogenesis in HAEC cells. |
T12 | 1818-2047 | Sentence | denotes | Since this enzyme is a target for VEGF action and LacCer serves as a lipid second messenger in inducing angiogenesis in vitro and in vivo, novel therapeutic approaches may be developed using our findings to mitigate colon cancer. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 14-30 | Glycan | denotes | lactosylceramide | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T2 | 256-272 | Glycan | denotes | lactosylceramide | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T3 | 274-280 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T4 | 286-292 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T5 | 389-395 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T6 | 548-554 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T7 | 1034-1040 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T8 | 1187-1193 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T9 | 1520-1526 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
T10 | 1868-1874 | Glycan | denotes | LacCer | https://api.glycosmos.org/wurcs2image/latest/png/binary/G84224TW |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 14-30 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | lactosylceramide | http://www.glycoepitope.jp/epitopes/EP0078 |
T2 | 256-272 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | lactosylceramide | http://www.glycoepitope.jp/epitopes/EP0078 |
T3 | 274-280 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T4 | 286-292 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T5 | 389-395 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T6 | 548-554 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T7 | 1034-1040 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T8 | 1187-1193 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T9 | 1520-1526 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
T10 | 1868-1874 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | LacCer | http://www.glycoepitope.jp/epitopes/EP0078 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 803-808 | OrganismTaxon | denotes | human | 9606 |
T2 | 1206-1211 | OrganismTaxon | denotes | human | 9606 |
T3 | 1257-1262 | OrganismTaxon | denotes | human | 9606 |
T4 | 1439-1443 | OrganismTaxon | denotes | mice | 10088 |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 498-503 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/MAT_0000526 |
T2 | 613-618 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/MAT_0000526 |
T3 | 1222-1226 | Body_part | denotes | vein | http://purl.obolibrary.org/obo/MAT_0000037 |
T4 | 2034-2039 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/MAT_0000526 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 41-57 | Body_part | denotes | endothelial cell | http://purl.obolibrary.org/obo/CL_0000115 |
T2 | 475-492 | Body_part | denotes | Endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T3 | 498-503 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
T4 | 613-618 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
T5 | 619-625 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
T6 | 626-643 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T7 | 809-826 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T8 | 1072-1082 | Body_part | denotes | fibroblast | http://purl.obolibrary.org/obo/CL_0000057 |
T9 | 1212-1226 | Body_part | denotes | umbilical vein | http://purl.obolibrary.org/obo/UBERON_0002066 |
T10 | 1227-1244 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T11 | 1270-1287 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
T12 | 1662-1670 | Body_part | denotes | platelet | http://purl.obolibrary.org/obo/CL_0000233 |
T13 | 1671-1687 | Body_part | denotes | endothelial cell | http://purl.obolibrary.org/obo/CL_0000115 |
T14 | 1759-1767 | Body_part | denotes | monocyte | http://purl.obolibrary.org/obo/CL_0000576|http://purl.obolibrary.org/obo/CL_0001054 |
T16 | 2034-2039 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 41-57 | Cell | denotes | endothelial cell | http://purl.obolibrary.org/obo/CL:0000115 |
T2 | 475-492 | Cell | denotes | Endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |
T3 | 626-643 | Cell | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |
T4 | 809-826 | Cell | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |
T5 | 1072-1082 | Cell | denotes | fibroblast | http://purl.obolibrary.org/obo/CL:0000057 |
T6 | 1222-1244 | Cell | denotes | vein endothelial cells | http://purl.obolibrary.org/obo/CL:0002543 |
T7 | 1263-1287 | Cell | denotes | aortic endothelial cells | http://purl.obolibrary.org/obo/CL:0002544 |
T8 | 1662-1670 | Cell | denotes | platelet | http://purl.obolibrary.org/obo/CL:0000233 |
T9 | 1671-1687 | Cell | denotes | endothelial cell | http://purl.obolibrary.org/obo/CL:0000115 |
T10 | 1759-1767 | Cell | denotes | monocyte | http://purl.obolibrary.org/obo/CL:0000576|http://purl.obolibrary.org/obo/CL:0001054 |